Russell Investments Group’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-36
Closed -$1.41K 4384
2026
Q1
$1.41K Hold
36
﹤0.01% 4031
2025
Q4
$1.31K Hold
36
﹤0.01% 4034
2025
Q3
$1.4K Sell
36
-107
-75% -$4.03K ﹤0.01% 4029
2025
Q2
$5.23K Buy
+143
New +$4.94K ﹤0.01% 3445

Other funds holding BOUT

Russell Investments Group's BOUT Position: Q2 2026 in Review

Russell Investments Group sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2026, closing a stake of 36 shares — an estimated $1.41K sold.

Russell Investments Group first reported a position in BOUT in Q2 2025 and held it in 4 quarters. The position peaked at $5.23K in Q2 2025. 12 funds tracked by Wall St. Rank hold BOUT as of Q2 2026.

  • Russell Investments Group reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2026 after selling out during the quarter.
  • Russell Investments Group sold 36 CapForce IBD Breakout Opportunities ETF shares in Q2 2026, an estimated $1.41K.
  • Russell Investments Group first reported a position in CapForce IBD Breakout Opportunities ETF in Q2 2025 and held it in 4 quarters.
  • Russell Investments Group's CapForce IBD Breakout Opportunities ETF position peaked at $5.23K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.